Emiko Takeuchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emiko Takeuchi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Aya Yokota
Universite Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell
1 shared publication Chen-Yi Lai
Division of Stem Cell Processing, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo 108-0071, Japan
1 shared publication- Hajime Takayama
Graduate School of Science and Technology, Kyoto Institute of Technology
1 shared publication Hiromitsu Nakauchi
Division of Stem Cell Therapy, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo 108-0071, Japan Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305
1 shared publication- Makoto Otsu
Division of Stem Cell Therapy, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan
1 shared publication Masaaki Higashihara
Department of Hematology, Kitasato University School of Medicine, Kanagawa 252-0374, Japan
1 shared publication
Latest Publications
- Open Access
- 8 August 2016
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 213 (9) , 1865-1880
Multiple allogeneic progenitors in combination function as a unit to support early transient hematopoiesis in transplantation
Cord blood (CB) is a valuable donor source in hematopoietic cell transplantation. However, the initial time to engraftment in CB transplantation (CBT) is often delayed because of low graft cell numbers. This limits the use of CB. To overcome this cell dose barrier, we modeled an insufficient dose CBT setting in lethally irradiated mice and then added hematopoietic stem/progenitor cells (HSCs/HPCs; HSPCs) derived from four mouse allogeneic strains. The mixture of HSPCs rescued recipients and significantly accelerated hematopoietic recovery. Including T cells from one strain favored single-donor chimerism through graft versus graft reactions, with early hematopoietic recovery unaffected. Furthermore, using clinically relevant procedures, we successfully isolated a mixture of CD34+ cells from multiple frozen CB units at one time regardless of HLA-type disparities. These CD34+ cells in combination proved transplantable into immunodeficient mice. This work provides proof of concept that when circumstances require support of hematopoiesis, combined multiple units of allogeneic HSPCs are capable of early hematopoietic reconstitution while allowing single-donor hematopoiesis by a principal graft.
- 8 August 2016
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 213 (9) , 1865-1880
Open AccessMultiple allogeneic progenitors in combination function as a unit to support early transient hematopoiesis in transplantation
Cord blood (CB) is a valuable donor source in hematopoietic cell transplantation. However, the initial time to engraftment in CB transplantation (CBT) is often delayed because of low graft cell numbers. This limits the use of CB. To overcome this cell dose barrier, we modeled an insufficient dose CBT setting in lethally irradiated mice and then added hematopoietic stem/progenitor cells (HSCs/HPCs; HSPCs) derived from four mouse allogeneic strains. The mixture of HSPCs rescued recipients and significantly accelerated hematopoietic recovery. Including T cells from one strain favored single-donor chimerism through graft versus graft reactions, with early hematopoietic recovery unaffected. Furthermore, using clinically relevant procedures, we successfully isolated a mixture of CD34+ cells from multiple frozen CB units at one time regardless of HLA-type disparities. These CD34+ cells in combination proved transplantable into immunodeficient mice. This work provides proof of concept that when circumstances require support of hematopoiesis, combined multiple units of allogeneic HSPCs are capable of early hematopoietic reconstitution while allowing single-donor hematopoiesis by a principal graft.
- 11 September 2004
- Published by Elsevier in Molecular Immunology
- Vol. 42 (1) , 71-78
Prominent dominant negative effect of a mutant Fas molecule lacking death domain on cell-mediated induction of apoptosis
- 11 September 2004
- Published by Elsevier in Molecular Immunology
- Vol. 42 (1) , 71-78
Prominent dominant negative effect of a mutant Fas molecule lacking death domain on cell-mediated induction of apoptosis